Back to search
FDAFDA · Food and drugs·Recall number D-0374-2024

Betimol (timolol ophthalmic solution) 0.5%, 15mL bottles, Rx only, Manufactured for: Thea Pharma Inc. Lexington, MA 02420, NDC 82584-002-15

Published March 20, 2024 · Recall initiated: March 5, 2024

Summary

FDA records drug Class II recall D-0374-2024, published March 20, 2024 and initiated March 5, 2024. Recalling firm: Thea Pharma, Inc.; Status: Terminated; Reported quantity: 5,476 bottles; Lot: Lot #: 435019, Exp. Date 11/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: Out of specification for volume and compromised container closure.

What to do

Voluntary: Firm initiated · Letter

Get an email if BETIMOL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
BETIMOL
Manufacturer
Thea Pharma, Inc.
Distributor
Product was distributed nationwide within the United States
UPC
0382584002053
Lot
Lot #: 435019, Exp. Date 11/2024
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Betimol (timolol ophthalmic solution) 0.5%, 15mL bottles, Rx only, Manufactured for: Thea Pharma Inc. Lexington, MA 02420, NDC 82584-002-15 recalled?

Yes. FDA published recall D-0374-2024 on March 20, 2024. Reported hazard: Lack of Assurance of Sterility: Out of specification for volume and compromised container closure.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: BETIMOL. UPC: 0382584002053.